Targeting intratumoral heterogeneity in TNBC with novel combinations of FDA-approved drugs

被引：0
|
作者：
Truchan, Nathan A. [1 ]
Burnett, Joseph P. [1 ]
Sun, Duxin [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-968
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
968
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
    Bhat-Nakshatri, Poornima
    Goswami, Chirayu P.
    Badve, Sunil
    Sledge, George W., Jr.
    Nakshatri, Harikrishna
    SCIENTIFIC REPORTS, 2013, 3
  • [42] Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs
    Vojnits, Kinga
    Feng, Zhuohang
    Johnson, Paige
    Porras, Deanna
    Manocha, Ekta
    Vandersluis, Sean
    Pfammatter, Sibylle
    Thibault, Pierre
    Bhatia, Mick
    CANCER LETTERS, 2024, 599
  • [43] Identification of natural products and FDA-approved drugs for targeting cancer stem cell (CSC) propagation
    Bonuccelli, Gloria
    Sotgia, Federica
    Lisanti, Michael P.
    AGING-US, 2022, 14 (23): : 9466 - 9483
  • [44] Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity
    Poornima Bhat-Nakshatri
    Chirayu P. Goswami
    Sunil Badve
    George W. Sledge
    Harikrishna Nakshatri
    Scientific Reports, 3
  • [45] Cancer Therapy Potential Unveiled: FDA-Approved Drugs Targeting Glutaminase for Breast Cancer Treatment
    Mirshekaran, Raziyeh
    Ahmadi, Khadijeh
    Shahbazi, Behzad
    Farshidfar, Gholamreza
    Eftekhar, Ebrahim
    Kavousipour, Soudabeh
    CHEMISTRYSELECT, 2024, 9 (24):
  • [46] Screening FDA-approved drugs in a zebrafish model of ocular trauma identifies novel cytoprotectants
    Eroglu, Arife
    Nelson, Jeffrey Jeff
    Malapani-Scala, Aurel
    Mumm, Jeff S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [47] High-throughput Screening of FDA-approved Drugs Identifies Novel Inhibitors of Macropinocytosis
    Lin, Hui-Ping
    Ghoshal, Pushpankur
    Singla, Bhupesh
    Faulkner, Jessica L.
    Shaw, Mary C.
    O'Connor, Paul M.
    She, Jin-Xiong
    de Chantemele, Eric J. Belin
    Csanyi, Gabor
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38
  • [48] Preclinical Testing of FDA-Approved Drugs Repurposed for Potential Novel Tocolytic Use.
    Siricilla, Shajila
    Hansen, Christopher J.
    Staub, Jeremy D.
    Walker, Jordan
    Brown, Alexus J.
    Benjamin, John
    Herington, Jennifer L.
    REPRODUCTIVE SCIENCES, 2024, 31 : 119A - 120A
  • [49] Evaluating physiochemical properties of FDA-approved orally administered drugs
    Reese, Tanner C.
    Devineni, Anvita
    Smith, Tristan
    Lalami, Ismail
    Ahn, Jung-Mo
    Raj, Ganesh V.
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (02) : 225 - 238
  • [50] FDA-Approved Anti-Obesity Drugs in the United States
    Daneschvar, Homayoun L.
    Aronson, Mark D.
    Smetana, Gerald W.
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08): : 879.e1 - 879.e6
12345